The Al Hammadi Company for Development and Investment employs 3,245 people and manages four subsidiaries, including the 600-bed Al Hammadi Hospital Al Nuzha, and the 428-bed Al Hammadi Hospital Al Suwaidi. The company recorded assets of $656 million and revenues of $178.5 million in the first nine months of 2021. In late 2021, it acquired 35% of the Sudair Pharmaceuticals Company, valued at $31.5 million.